[Plasmapheresis in the treatment of rapidly progressing glomerulonephritis]. 1989

Iu S Milovanov, and Iu V Komiagin, and E M Shilov, and V M Ermolenko

The authors are of the opinion that plasmapheresis (PP) combined with immunosuppressant therapy is an effective and a relatively safe method for the treatment of rapidly progressing glomerulonephritis (RPGN). Introduction of PP in multimodality treatment of RPGN made it possible to arrest rapidly progressing renal failure in all 6 treated patients. After PP treatment was over, renal function was recovered completely in 3 patients. One patient manifested the retention of renal failure of medium degree while rare hemodialysis sessions permitted one to control water-electrolyte disorders. In two patients the discontinuation of PP treatment resulted in the progress of renal failure. The data obtained do not make it possible to relate the improvement of renal function exclusively to the action of PP, since all the patients received immunosuppressants. Nevertheless, in 2 cases, the improvement could be attributed to PP, for its discontinuation in these patients (without any changes in the remaining treatment) brought about again the progress of renal failure.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D010956 Plasmapheresis Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use. Double Filtration Plasmapheresis,Therapeutic Immunoadsorption,Therapeutic Plasma Adsorption,Therapeutic Plasmapheresis,Adsorption, Therapeutic Plasma,Adsorptions, Therapeutic Plasma,Double Filtration Plasmaphereses,Filtration Plasmapheresis, Double,Immunoadsorption, Therapeutic,Plasma Adsorption, Therapeutic,Plasmaphereses,Plasmapheresis, Double Filtration,Plasmapheresis, Therapeutic,Therapeutic Immunoadsorptions,Therapeutic Plasma Adsorptions,Therapeutic Plasmaphereses
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014883 Water-Electrolyte Imbalance Disturbances in the body's WATER-ELECTROLYTE BALANCE. Imbalance, Water-Electrolyte,Imbalances, Water-Electrolyte,Water Electrolyte Imbalance,Water-Electrolyte Imbalances

Related Publications

Iu S Milovanov, and Iu V Komiagin, and E M Shilov, and V M Ermolenko
January 1995, Terapevticheskii arkhiv,
Iu S Milovanov, and Iu V Komiagin, and E M Shilov, and V M Ermolenko
September 1978, Klinicheskaia meditsina,
Iu S Milovanov, and Iu V Komiagin, and E M Shilov, and V M Ermolenko
August 1992, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Iu S Milovanov, and Iu V Komiagin, and E M Shilov, and V M Ermolenko
November 1997, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis,
Iu S Milovanov, and Iu V Komiagin, and E M Shilov, and V M Ermolenko
July 1983, The International journal of artificial organs,
Iu S Milovanov, and Iu V Komiagin, and E M Shilov, and V M Ermolenko
November 1991, Deutsche medizinische Wochenschrift (1946),
Iu S Milovanov, and Iu V Komiagin, and E M Shilov, and V M Ermolenko
October 1978, The American journal of medicine,
Iu S Milovanov, and Iu V Komiagin, and E M Shilov, and V M Ermolenko
January 1982, Vutreshni bolesti,
Iu S Milovanov, and Iu V Komiagin, and E M Shilov, and V M Ermolenko
November 1984, Southern medical journal,
Iu S Milovanov, and Iu V Komiagin, and E M Shilov, and V M Ermolenko
January 1975, Revista do Hospital das Clinicas,
Copied contents to your clipboard!